Valuation: Iconovo AB

Market Cap 103M 10.82M 9.35M 8.78M 7.99M 15.02M 1.03B 15.26M 40.23M 518M 40.63M 39.75M 1.72B P/E 2026 *
-26.8x
P/E 2027 * -3.06x
Enterprise Value 63.9M 6.72M 5.8M 5.45M 4.96M 9.33M 643M 9.48M 24.99M 322M 25.23M 24.68M 1.07B EV / Sales 2026 *
2.2x
EV / Sales 2027 * -
Free-Float
39.74%
Yield 2026 *
-
Yield 2027 * -
1 week+11.69%
Current month+3.88%
1 month-1.83%
3 months-8.94%
6 months-2.73%
Current year-6.14%
1 week 1.04
Extreme 1.035
1.1
1 month 0.87
Extreme 0.87
1.1
Current year 0.87
Extreme 0.87
1.44
1 year 0.87
Extreme 0.87
2.79
3 years 0.87
Extreme 0.87
18.5
5 years 0.87
Extreme 0.87
90
10 years 0.87
Extreme 0.87
99.8
Manager TitleAgeSince
Chief Executive Officer 59 2025-10-30
Director of Finance/CFO 63 2023-03-31
Chief Operating Officer 62 2015-12-31
Director TitleAgeSince
Chairman 65 2012-12-31
Director/Board Member 62 2012-12-31
Director/Board Member 67 2012-12-31
Date Insider Type Main position Quantity % Market Cap.
9/22/22 Buy

Founder

500 0.0057%
9/21/22 Buy

Chief Executive Officer

1,000 0.0113%
9/16/22 Buy

Director

840 0.0095%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+11.69%-47.55%-94.06% 10.82M
-0.49%-2.10%-29.04%-47.98% 14.94B
-3.07%-4.93%+27.35%+119.91% 4.61B
-0.78%-2.11%+252.70%+197.44% 3.27B
-0.92%-1.76%-28.84%-30.69% 2.51B
-0.98%-1.04%-30.87%-28.56% 1.86B
0.00%+3.97%+9.17%-18.63% 1.29B
+3.08%+2.66%+5.46%-12.54% 1.09B
-0.89%-3.42%-4.50%+13.97% 983M
-1.19%-1.78%+20.29%+31.75% 974M
Average -0.52%+1.08%+17.42%+13.06% 3.15B
Weighted average by Cap. -0.85%-1.51%+13.33%+11.32%

Financials

2026 *2027 *
Net sales 29M 3.05M 2.63M 2.48M 2.25M 4.23M 292M 4.3M 11.34M 146M 11.45M 11.2M 485M -
Net income -3M -315K -272K -256K -233K -438K -30.17M -445K -1.17M -15.11M -1.18M -1.16M -50.2M -34M -3.58M -3.09M -2.9M -2.64M -4.96M -342M -5.04M -13.29M -171M -13.42M -13.13M -569M
Net Debt -39M -4.1M -3.54M -3.33M -3.03M -5.69M -392M -5.78M -15.25M -196M -15.4M -15.06M -653M 1M 105K 90.82K 85.35K 77.62K 146K 10.06M 148K 391K 5.04M 395K 386K 16.73M
Logo Iconovo AB
Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
Employees
12
Date Price Change Volume
26-08-14 SEK 1.070 0.00% 4,625
26-08-13 SEK 1.070 -2.73% 52,950
26-08-12 SEK 1.100 +5.77% 43,299
26-08-11 SEK 1.040 +2.97% 24,337
26-08-10 SEK 1.010 +5.43% 82,641

Quarterly revenue - Rate of surprise